INTELLIGENCE IN ACTION

PRICE TRANSPARENCY

Prescription price transparency is critical to lowering patients’ out-of-pocket costs and preventing “sticker shock” at the pharmacy, which negatively impacts medication adherence and patient safety.

Recent Articles

May 21, 2019

An Urgent Call for Transformation: Prescribers Need Better Information and a Streamlined Specialty Prescribing Process

Read more...
May 20, 2019

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

Read more...
April 15, 2019

Older, Sicker Patients Will Benefit from Real-Time Benefit Tools, So Let’s Not Delay Using Them.

Read more...
March 25, 2019

HIMSS19 Showed Glimpses of a Bright Future, But Also Problem Solving in the Here and Now

Read more...
March 15, 2019

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

Read more...
February 19, 2019

Disrupting the Drug Cost Trajectory: Dr. Michelle Mello on Making Medications Affordable

Read more...
February 13, 2019

Prescribers and Patients are Working Together to Save Time, Money and Hassle

Read more...
December 18, 2018

Federal Government Takes Action to Spur Greater Use of Prescription Price Transparency Tools at the Point of Care

Read more...
December 03, 2018

How Prescribers are Saving Their Patients Thousands of Dollars on Drugs

Read more...
November 14, 2018

Reinventing the Health IT Adoption Curve: Price Transparency at the Point of Care

Read more...
September 17, 2018

Actionable Intelligence at the Point of Care can Help Prevent Physician Burnout

Read more...
September 07, 2018

Surescripts Tackles Prescription Abandonment with Point-of-Care Information That Supports Patient-Provider Shared Decision Making

Read more...
August 28, 2018

Five Questions: Mary Ann Chaffee on Price Transparency, Public Health and the Notorious R.B.G.

Read more...
August 01, 2018

Patients, Pocketbooks and a Podcast on Prescription Price Transparency

Read more...
April 23, 2018

Patients’ Out-of-Pocket Cost Should Weigh Into Prescribing Decisions

Read more...
March 22, 2018

HIMSS18 Panel Gets Candid About Prescription Price Transparency

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX